AEON Biopharma
AEON • AMEX
AEON Biopharma is a biotechnology company in the healthcare sector trading on AMEX, led by CEO Robert Bancroft, with a market cap of $29.4M.
CEORobert Bancroft
Next Earnings
Upcoming earnings announcement for AEON Biopharma
Date
Wednesday, May 13, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
Earnings History
Past 10 earnings reports for AEON Biopharma
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 30, 2026 | Q4 2025 | -$3.72Est: -$0.26 | -1330.8% | - | — |  10-K |
| Nov 14, 2025 | Q3 2025 | -$0.39Est: -$0.43 | +9.3% | - | — | 10-Q |
| Aug 12, 2025 | Q2 2025 | -$0.60Est: -$0.35 | -71.4% | - | — | 10-Q |
| May 14, 2025 | Q1 2025 | $2.28 | — | - | — | 10-Q/A |
| Mar 24, 2025 | Q4 2024 | $3.75 | — | - | — | 10-K |
| Nov 13, 2024 | Q3 2024 | -$11.52Est: -$11.52 | 0.0% | - | — | 10-Q |
| Aug 12, 2024 | Q2 2024 | -$11.52Est: -$13.68 | +15.8% | - | — | 10-Q |
| May 14, 2024 | Q1 2024 | -$228.24Est: -$28.08 | -712.8% | - | — | — |
| Mar 29, 2024 | Q4 2023 | -$51.12 | — | - | — | — |
| Nov 13, 2023 | Q3 2023 | $82.80 | — | - | — | — |